Beyond conventional immune-checkpoint inhibition — novel immunotherapies for renal cell carcinoma
David A. Braun(Yale Cancer Center), Toni K. Choueiri(Harvard University), Eliezer M. Van Allen(Dana-Farber Cancer Institute), Ronan Flippot(Institut Gustave Roussy), Laure Hirsch(Harvard University), Catherine J. Wu(Dana-Farber Cancer Institute), Ziad Bakouny(Dana-Farber Cancer Institute)
Cited by 382
Related Papers
The Immune Landscape of Cancer
|Immunity|2018|6.2k
Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq
|Science|2016|5.3k
Integrative Clinical Genomics of Advanced Prostate Cancer
|Cell|2015|3.6k
Pembrolizumab as Second-Line Therapy for Advanced Urothelial Carcinoma
|New England Journal of Medicine|2017|3.4k
Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study
|The Lancet|2020|1.8k